jRCT1030260011
招募中
不适用
An observational study to verify the safety and efficacy of treatment with JWT for patients with advanced cancer (stage 3 or later) using standard and advanced testing indicators
未提供0 个研究点目标入组 10 人开始时间: 待定
适应症Cancer
概览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 10
概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- All
入选标准
- •Cases where JWT was used in patients who were not responding to standard drugs
排除标准
- •Patients who were unable to continue the study due to hypersensitivity or allergic reactions to JWT.
- •Patients who are taking other drugs concomitantly, or patients who have previously participated in clinical trials and have not yet passed one month since the last dose of the study drug.
- •Patients who are otherwise deemed inappropriate by the principal investigator or co-investigator.
研究者
相似试验
招募中
不适用
An observational study to verify the safety and effectiveness of treatment using organic iodine + MD(alpha) for patients with advanced cancer (stage 3 or later) using standard and advanced test indicatorsCancerjRCT103026001610
已完成
1 期
Study is designed to assess the safety and tolerability of ceralasertib at increasing doses in combination with other anti-cancer treatment in patients with advanced tumours2023-505006-41-00AstraZeneca AB100
招募中
1 期
Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants with Advanced Solid TumorsAdvanced Malignant Solid Tumors2025-523931-21-00Genmab A/S77
招募中
不适用
A study to test how well different doses of BI 3820768 are tolerated by people with advanced cancer (solid tumours)Germ Cell Tumour, Endometrial Cancer and Ovarian CancerjRCT2031260005187
招募中
不适用
An observational study on the safety and therapeutic effects of oral administration of Quercefit in subjects with aging symptomsAge-related decline in physical function and aging-associated symptomsjRCT103026001810